News Release
FOR IMMEDIATE RELEASE
Date: February 24, 2012
Contact: Rich Isaacson
Number: (313) 234-4310

Two Booneville, KY Pharmacists Pay $60,000 in
Controlled Substances Case

LEXINGTON, KY— The Drug Enforcement Administration and The United States Attorney’s Office for the Eastern District of Kentucky jointly announced that two pharmacists, James F. Carrico and James D. Maze, who both work at Booneville Discount Drugs in Booneville, Kentucky, agreed to pay the United States Government $60,000 to settle civil claims concerning the manner in which the pharmacy tracked and dispensed controlled substances.

According to the settlement, from May 2008 through September 2009, Carrico’s DEA registrant number was used to improperly dispense controlled substances on 11 occasions. The government also contends there were 21 instances where Maze’s DEA registrant number was used to dispense controlled substances without a prescription and physician authorization. Additionally, the Carrico settlement agreement alleges that the pharmacy failed to track and maintain accurate inventory records of various controlled substances.

Under federal law, a pharmacist may only dispense controlled substances in accordance with a written prescription signed by a practitioner. The law also places certain restrictions and limitations on a pharmacist’s ability to fill prescriptions for controlled substances. Pharmacists must maintain accurate inventory reports for controlled substances. As it relates to pharmacists, a DEA registrant number is an identification code assigned to them after they’ve been approved by the DEA to fill prescriptions for controlled substances that are written by a registered health care provider.

The U.S. Attorney’s Office claims that a DEA audit showed there were 65 instances where Booneville Discount Drugs failed to maintain accurate controlled substance inventory records over the course of a year and a half. The audit revealed both shortages and surpluses of controlled substances.

Controlled substances are drugs or other substances regulated by the government. Carrico has paid $40,000, and Maze paid $20,000. This agreement is neither an admission of liability on the part of the pharmacists nor a concession by the United States that its claims are not well founded.

The investigation was conducted by the DEA and the U.S. Attorney’s Office. Assistant U.S. Attorney Valorie Smith represented the government in this case.

#   #   #